Zentalis Pharmaceuticals maintains a lean, specialized workforce numbering approximately 106 full-time employees, reflecting recent organizational restructuring and headcount adjustments typical of clinical-stage biotechnology firms. This compact team primarily consists of expert scientists, clinical research directors, regulatory compliance specialists, and executive management focused entirely on advancing the company's targeted oncology drug pipeline through complex clinical trials.